ABSTRACT: Yellow head virus (YHV) is an invertebrate nidovirus that has caused mass mortality of cultured Penaeus monodon in Asia. In this study, we investigated whether mouse polyclonal antiserum raised against the YHV gp116 or gp64 structural glycoproteins could neutralize YHV infectivity as determined using an in vitro quantal assay in primary cultures of lymphoid organ cells. Antigp116 antiserum showed virus-neutralizing activity whereas anti-gp64 antiserum failed to inhibit infection. The results suggest that gp116 antiserum blocks binding of virions to cellular receptors to facilitate YHV entry into lymphoid organ cells. 
INTRODUCTION
Yellow head virus (YHV) has caused mass mortalities in Penaeus monodon cultured in Asia and is an enveloped virus with a positive-sense, single-stranded RNA genome (Wongteerasupaya et al. 1995 , Tang & Lightner 1999 . Sequence analysis of the genomes of YHV and the closely related gill-associated virus (GAV) from Australia has identified a long open reading frame (ORF) that contains motifs with distinct homologies to function domains present in nidovirus ORF1b coding sequences (Cowley et al. 1999 , Sittidilokratna et al. 2002 . Also, as in all nidoviruses, YHV and GAV possess a pseudoknot element in the genome region in which ORF1a overlaps ORF1b, thus facilitating translation of an ORF1a-1b polyprotein (pp1ab) by a -1 ribosomal frameshift mechanism (Cowley et al. 2000 , Sittidilokratna et al. 2002 . Based on their genome organisation and on the transcription of 3'-coterminal subgenomic RNAs in GAV (Cowley et al. 2000) , YHV and GAV have recently been classified in new taxa within the Nidovirales, family Roniviridae, genus Okavirus (Cowley et al. 2000 , Mayo 2002 , Sittidilokratna et al. 2002 .
Coronavirus particles contain 3 or 4 prominent structural proteins: an RNA-associated nucleocapsid (N) protein, an integral membrane (M) protein, a spike (S) glycoprotein and some viruses also possess a surfaceexposed, hemagglutinin-esterase (HE) protein (Spaan et al. 1988) . As its name implies, the ~180 kDa S glycoprotein constitutes the spikes projecting from the virion envelope and possesses important biological activities associated with cell receptor binding and membrane fusion to allow cell entry (Holmes et al. 1981 , Williams et al. 1991 , Spaan et al. 1988 , Klasse & Sattertau 2002 . Monoclonal or polyclonal antibodies to spike proteins of coronaviruses of mice (Luytjes et al. 1989) , birds (Mockett et al. 1984) , pigs (Jimenez et al. 1986 ), cats (Corapi et al. 1992 ) and cattle (Deregt & Babiuk 1987) have been shown to neutralize virus infectivity.
YHV particles are morphologically distinct from coronaviruses in that they are rod-shaped with diffuse surface projections (Wongteerasupaya et al. 1995) . YHV virions contain 3 major structural proteins with estimated molecular masses of 116 kDa (gp116), 64 kDa (gp64) and 20 kDa (p20) (Nadala et al. 1997 , Wang & Chang 2000 , Jitrapakdee et al. 2003 . The glycoproteins gp116 and gp64 are proteolytic products of the polyprotein encoded by the ORF3 gene. The ORF3 polyprotein contains 6 highly hydrophobic, predicted transmembrane domains and proteolytic cleavage occurs at the C-terminal positions of transmembrane domains 2 and 5 (Jitrapakdee et al. 2003) . Cleavage generates a ~28 kDa N-terminal ORF3 fragment comprising a putative triple-membrane spanning protein of unknown function in addition to the membraneanchored gp116 and gp64 glycoproteins that are incorporated into virions. According to the predicted topology of the ORF3 polyprotein, gp116 is a type III transmembrane glycoprotein anchored in the envelope at 2 positions in its C-terminus with both N-and Ctermini exposed and gp64 is a type I glycoprotein anchored at its C-terminal transmembrane domain. The amino acid sequences of gp116 and gp64 contain no heptad-repeat patterns indicative of the coiled-coil structures found in the structural glycoproteins of coronaviruses and toroviruses (de Groot et al. 1987) , which likely accounts for the absence of rigid stemcontaining surface peplomers on the YHV particle. The distinct virion structure of YHV thus raises several interesting questions concerning the mechanism of infection and which structural glycoprotein facilitates cell attachment and/or entry. In this study we have obtained evidence that gp116 but not gp64 contains virus-neutralizing epitopes and thus has an essential role in infecting susceptible cells.
MATERIALS AND METHODS
Virus purification. A Thai YHV isolate (kindly provided by Dr. Boonsirm Withyachumnarnkul) was used to infect 200 juvenile Penaeus monodon shrimp (average weight 20 g) by intramuscular injection as previously described (Wongterrasupaya et al. 1995) . At 48 to 72 h post injection, hemolymph was collected and pooled and YHV was purified using Urograffin (Schering) gradient centrifugation (Wongteerasupaya et al. 1995) . Purified YHV was aliquoted and stored frozen at -80°C.
Primary lymphoid (Oka) cell cultures. Primary cell cultures were prepared from the lymphoid (Oka) organ of Penaeus monodon as previously described (Assavalapsakul et al. 2003) . Briefly, Oka organs were collected from approximately 100 juvenile P. monodon (average weight 20 g), washed 6 times with sterile 2 × Leibovitz's L-15 (GIBCO, BRL) containing 15% fetal bovine serum, 5% lactabumin, 100 units ml -1 penicillin and 100 µg ml -1 streptomycin and then minced into small pieces in the same medium. The minced tissue was seeded onto a 96-well tissue culture plate in the same medium supplemented with 15% shrimp meat extract. The cells were grown to monolayer at 28°C.
Anti-gp116 and anti-gp64 polyclonal antisera production. Gel slices containing gp116 or gp64 of YHV were excised from a Coomassie Brilliant Blue-stained 10% SDS-polyacrylamide gel. Each gel slice was dried under vacuum using a speedvac centrifuge and then ground in liquid nitrogen into a fine powder. The powdered acrylamide containing gp116 or gp64 was emulsified in complete Freund's adjuvant (Sigma Chemical) and injected peritoneally into female BALB/c mice as described by Harlow & Lane (1988) . The mice were subsequently injected 3 times at 2 wk intervals with the same antigen emulsified with incomplete Freund's adjuvant (Sigma Chemical). Antiserum was collected 1 wk after the third injection.
Immunoblot analysis. YHV proteins (500 ng) were resolved in a 10% SDS-polyacrylamide gel and transferred onto nitrocellulose membranes using a SemiDry transblot apparatus (BioRad). The membranes were incubated with either anti-gp116 or anti-gp64 antiserum diluted 1:2000 in 5% skim milk in phosphatebuffered saline containing 0.2% Tween-20 (PBST) for 1 h at room temperature (25°C). Excess antiserum was removed by successive washes in PBST, and the membrane was then probed with horseradish peroxidaseconjugated goat anti-mouse secondary antibody (Sigma Chemical) diluted 1:4000 in 5% skim milk in PBST. Antigen-antibody complexes were visualized using the ECL Plus Western Blotting Detection Reagent (Amersham Pharmacia Biotech).
YHV inhibition tests in primary cell cultures. Serial 10-fold dilutions of purified YHV were prepared in the same culture medium as described above for cell cultivation and were then preincubated with anti-gp116, anti-gp64 or irrelevant antiserum to human growth hormone at a dilution of 1:500 for 90 min at room temperature. Aliquots (50 µl) of each antiserum-YHV mixture were inoculated into 4 wells and incubated for 90 min at room temperature. After incubation, 150 µl of medium was added and the cells were maintained at 28°C for 7 d. Viral infectivity was determined by crystal violet staining to distinguish between viable and non-viable cells and TCID 50 end points were determined as described by Reed & Muench (1938) .
RESULTS AND DISCUSSION
The specificity of polyclonal antisera against gp116 and gp64 was demonstrated by their binding only to proteins with molecular mass of 128 kDa (Fig. 1B) or 71 kDa (Fig. 1C) derived from purified YHV. The sizes of the immuno-reactive proteins corresponded to the 2 major structural proteins from purified YHV (Fig. 1A) , although their estimated masses were apparently different from those previously reported (Jitrapakdee et al. 2003) . Even so, it is most likely that the respective 128 and 71 kDa protein bands recognized by our antisera corresponded to the gp116 and gp64 proteins previously reported. The apparent differences in molecular mass prediction may be due to differences in gel electrophoresis conditions or to the standard markers used. The apparent titer of the 2 antibodies was comparable as determined by dot blots in which both antisera could readily detect the corresponding proteins at the level of 5 ng (data not shown).
Incubation of anti-gp116, anti-gp64 and irrelevant polyclonal antisera with YHV prior to challenge of Oka organ cell monolayers resulted in neutralization of YHV infectivity only with anti-gp116 (Fig. 2) . In 3 separate experiments, there was an approximate 1-log reduction in TCID 50 ml -1 compared to that from controls without antiserum treatment. The reduction was antiserum specific since YHV preincubation with anti-human growth hormone antiserum did not affect viral titer. Interestingly, YHV preincubation with anti-gp64 did not inhibit YHV infectivity and similar results were observed for 3 independent experiments. This suggests that the gp116 surface glycoprotein of YHV contains virus neutralizing antigenic epitopes and that it may be involved in cell attachment and entry. Thus, it may be a good target for development of antibody-based, antiviral protectants or therapies. Although our anti-gp64 antiserum showed no inhibition to YHV infectivity, involvement of gp64 in YHV infectivity cannot be excluded. The fact that both anti-gp116 and anti-gp64 antiserum were produced against denatured proteins means that they would recognize mainly linear epitopes of the corresponding antigens. Thus, if neutralizing epitopes of gp64 were conformationally specific, it is possible that antiserum to linear epitopes would fail to neutralize its activity. Recently, an oral treatment strategy using bacterially expressed structural protein VP28 of white spot syndrome virus (WSSV) has been reported to lower the mortality rate of Penaeus monodon challenged with WSSV (Witteveldt et al. 2004 ). Our results suggest that similar experiments may be worthwhile using bacterially expressed gp116 to feed shrimp prior to challenge with YHV. 
